ENTITY
SK Bioscience

SK Bioscience (302440 KS)

165
Analysis
Health CareSouth Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
Refresh
bullishSK Bioscience
19 Mar 2021 06:29

SK Bioscience to KOSPI 200 Is a Done Deal & A Likely Deletion

This post has the latest update on KOSPI 200 June rebalancing and examines SK Bioscience's KOSPI 200 fast entry situation along with a likely...

Logo
387 Views
Share
bullishSK Bioscience
16 Mar 2021 08:40

Germany, France, Italy, & Spain Suspend AstraZeneca COVID-19 Vaccinations: Impact on SK Bioscience

While we remain bullish on the SK Bioscience IPO, the fact that 15 countries have decided to temporarily suspend AstraZeneca COVID-19 vaccines will...

Logo
217 Views
Share
bullishSK Bioscience
14 Mar 2021 13:04

SK Bioscience IPO: Allocation & Lockup Schedule

This post details SK Bioscience IPO's allocation results and lockup schedule (also the index float for KOSPI 200 fast-entry).

Logo
325 Views
Share
bullishSK Bioscience
09 Mar 2021 04:49

SK Bioscience IPO: Bookbuilding Results & KOSPI 200 Fast Entry

This post has SK Bioscience's IPO book-building results and examines the situation/likelihood of the KOSPI 200 fast entry.

Logo
272 Views
Share
bullishSK Bioscience
08 Mar 2021 22:50

Trading Strategy of SK Bioscience IPO Post Pricing

The IPO price of SK Bioscience was confirmed at 65,000 won per share, which is at the top of the IPO price range. The total demand ratio of the SK...

Logo
296 Views
Share
x